Cancer killed 6.7 million people around the world in 2002, and this figure isexpected to rise to 10.1 million in 2020. Approximately, 189.510 new cases ofbreast cancer were reported in 2007 in the United States, and 40.910 died in the same year. Both principles and practice of breast oncology are presented in this volume. Node negative breast cancer, sebaceous cancer of the breast, phyllodes tumors of the breast, metaplastic breast cancer, invasive breast cancer, and multifocal and multicenter breast cancers are discussed. Breast cancer detection is explained using high throughput, MicroRNA expression, computer-aided detection, in vivo imaging of angiogenesis, contrast-enhanced digital mammography, sentinel node biopsy, and cytology in nipple-aspirated fluid. Validation of breast cancer biomarkers using tissue microarrays, epigenetic markers in blood, and HER-2 and EGFR expression. Role of BRCA1 and BRCA2 genes and their protein products in breast cancer is included. The only book that discusses cancer diagnosis, therapy, and prognosis together in one volume Discusses the molecular processes that lead to the development and proliferation of cancer cells Includes recent major advances in cancer diagnosis and therapy assessmentThe text is supported throughout with illustrations The information in the book identifies patients with high likelihood of clinical benefits from a specific treatment
- ISBN: 978-1-4020-8368-6
- Editorial: Springer
- Encuadernacion: Cartoné
- Páginas: 1415
- Fecha Publicación: 01/07/2008
- Nº Volúmenes: 1
- Idioma: Inglés